Continuous Glucose Monitoring in Critically Ill

Stopped early · Not applicable

Conditions studied: Diabetes

In brief

The goal of this clinical research study is to learn if The Guardian® blood-sugar monitoring device can be used reliably in patients with high blood sugar who are receiving care in the ICU. Researchers will compare blood-sugar measurements from the study device with blood-sugar measurements from the standard "fingerstick" method of blood-sugar testing. This is being done to see if the new device can accurately measure blood sugar.

Key facts

Study ID

NCT00707434

Run by

M.D. Anderson Cancer Center

People needed

6

Starts

2008-06-01

Expected to finish

2016-09-01

Last updated by the study team

2020-03-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients in any of our University of Texas collaborative intensive care units.
• Critically ill patients on an insulin infusion protocol

You may not qualify if…

• Patients or their legal representatives who do not consent
• Patients with large areas of skin affected so as not to allow implantation of device.
• Patients < 18 years of age

Where it is running

• The University of Texas Southwestern Medical Center at Dallas — Dallas, Texas, United States
• University of Texas Medical Branch at Galveston — Galveston, Texas, United States
• University of Texas Health Science Center at Houston — Houston, Texas, United States
• University of Texas MD Anderson Cancer Center — Houston, Texas, United States
• University of Texas Health Science Center at San Antonio — San Antonio, Texas, United States
• University of Texas Health Science Center at Tyler — Tyler, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.